Advertisement Avantra renames to Courtagen - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Avantra renames to Courtagen

Avantra Biosciences, a provider of proteomic and genomic products and services to the life sciences industry, has renamed to Courtagen Life Sciences.

The company will continue to use the Avantra name for its proteomics portfolio, which includes the Avantra Biomarker System.

Courtagen CEO Brian McKernan said the name change reflects the company’s new strategic focus on developing advanced technologies in both genomic and proteomic areas and their commitment to bring additional needed technologies to the market.